Enterprise Sponsor
Arranta Bio, our enterprise sponsor for Microbiome and Scotland (birthplace of Arranta Bio’s founder
and CEO), is a world-class contract development and manufacturing organization (CDMO). Arranta Bio was
specifically established to serve companies seeking to develop and commercialize therapies targeting
the human microbiome. Arranta means “bold and daring” in Gaelic – a fitting name for a pioneering
company!
Lead by an experienced management team and technical experts with a proven track
record, Arranta Bio offers the expertise and resources necessary to develop and manufacture promising
new microbiome-based therapies that best meet the needs of patients.
With the COVID-19 pandemic, CDMOs are playing an increasingly important role in providing knowledge,
expertise and capacity in breakthrough areas of healthcare. The reliance of CDMO partners is
especially prevalent for novel technologies, including Live Biotherapeutic Products (LBPs) that target
the microbiome.
Because LBPs are like no other biologic, deep experience in dealing with
their nuances is essential to success. With more than 10 years of process development know-how and
expertise, Arranta Bio supports healthcare pioneers develop clinical therapies that target gut health
and microbiome-related diseases with their ALIVE Biotherapeutic ProductsTM (aLBP) program.
To best serve the evolving market needs, Arranta Bio is making bold moves to increase
capacity. The company has recently committed a $100M investment in their facilities to build
end-to-end microbiome capacity and support clients from early-stage process development through cGMP
clinical supply to commercialization.
With Arranta Bio’s experienced leadership team and
accumulated knowledge, the company supports the future of healthcare by providing development and
manufacturing services that help bring breakthrough therapies to market and transform the lives of
patients around the world.